REGISTRATION RIGHTS
AGREEMENT 



        This
Registration Rights Agreement (this “Agreement”) is made and entered
into as of May 27, 2004, by and among Alliance Pharmaceutical Corp., a New York
corporation (the “Company”), and the Investors named in that certain
Purchase Agreement by and among the Company and the Investors (the “Purchase
Agreement”)  





        This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date
hereof among the Company and the Investors (the “Purchase Agreement”).  





        The
Company and the Investors hereby agree as follows:  





        1.        Definitions.
Capitalized terms used and not otherwise defined herein that           are defined in the
Purchase Agreement will have the meanings given such terms in           the Purchase
Agreement. As used in this Agreement, the following terms have the           respective
meanings set forth in this Section 1:  





        “Affiliate”means,
with respect to any person, any other person which directly or indirectly controls, is
controlled by, or is under common control with, such person.  





        “Commission”means
the United States Securities and Exchange Commission.  





        “Exchange
Act” means the Securities Exchange Act of 1934, as amended.  





        “Holder”or
“Holders” means the holder or holders, as the case may be, from time to
time of Registrable Securities.  





        “Investors”means
the Investors identified in the Purchase Agreement and any Affiliate or permitted
transferee of any Investor who is a subsequent holder of any Warrants or Registrable
Securities.  





        “New
York Courts” means the state and federal courts sitting in the City of New York,
Borough of Manhattan.  





        “Proceeding”means
an action, claim, suit, investigation or proceeding (including, without limitation, an
investigation or partial proceeding, such as a deposition), whether commenced or
threatened.  





        “Prospectus”means
the prospectus included in a Registration Statement (including, without limitation, a
prospectus that includes any information previously omitted from a prospectus filed as
part of an effective registration statement in reliance upon Rule 430A promulgated under
the Securities Act), as amended or supplemented by any prospectus supplement, with
respect to the terms of the offering of any portion of the Registrable Securities covered
by a Registration Statement, and all other amendments and supplements to the Prospectus,
including post-effective amendments, and all material incorporated by reference or deemed
to be incorporated by reference in such Prospectus.  















        “Registrable
Securities” means: (i) the Shares, (ii) the Warrant Shares and (iii) any
securities issued or issuable upon any stock split, dividend or other distribution,
recapitalization or similar event, or any conversion price adjustment with respect to any
of the securities referenced in (i) or (ii) above.  





        “Registration
Statement” means the initial registration statement required to be filed in
accordance with Section 2(a)(i) and any additional registration statement(s) required to
be filed under Section 2(a)(ii), including (in each case) the Prospectus, amendments and
supplements to such registration statements or Prospectus, including pre- and
post-effective amendments, all exhibits thereto, and all material incorporated by
reference or deemed to be incorporated by reference therein.  





        “Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities
Act, as such Rule may be amended from time to time, or any similar rule or regulation
hereafter adopted by the Commission having substantially the same effect as such Rule.  





        “Rule
415” means Rule 415 promulgated by the Commission pursuant to the Securities
Act, as such Rule may be amended from time to time, or any similar rule or regulation
hereafter adopted by the Commission having substantially the same effect as such Rule.  





        “Rule
424” means Rule 424 promulgated by the Commission pursuant to the Securities
Act, as such Rule may be amended from time to time, or any similar rule or regulation
hereafter adopted by the Commission having substantially the same effect as such Rule.  





        “Securities
Act” means the Securities Act of 1933, as amended.  





        “Shares”means
the shares of Common Stock issued or issuable to the Investors pursuant to the Purchase
Agreement.  





        “Warrants”means
the Common Stock purchase warrants issued or issuable to the Investors pursuant to the
Purchase Agreement and to any placement agent identified in Schedule 3.1(u)to the
Purchase Agreement in accordance with the terms of the engagement or similar agreements
between the Company and any such agents.  





        “Warrant
Shares”means the shares of Common Stock issued or issuable upon exercise of the
Warrants.  




2 












        2.        Registration.  





	 	        (a)              Promptly
following the closing of the purchase and sale of the securities           contemplated
by the Purchase Agreement (the “Closing Date”) but           no later
than sixty (60) days after the Closing Date (the “Filing           Deadline”),
the Company shall prepare and file with the Commission a           Registration Statement
on Form SB-2 (or, if Form SB-2 is not then available to           the Company, on such
form of registration statement as is then available to           effect a registration
for resale of the Registrable Securities), covering the           resale of the
Registrable Securities in an amount at least equal to the number           of Shares plus
the number of shares of Common Stock necessary to permit the           exercise in full
of the Warrants. Such Registration Statement shall include the           “Plan of
Distribution” attached hereto as Exhibit A. Such           Registration
Statement also shall cover, to the extent allowable under the           Securities Act
and the rules promulgated thereunder (including Rule 416), such           indeterminate
number of additional shares of Common Stock resulting from stock           splits, stock
dividends or similar transactions with respect to the Registrable           Securities.
The Company shall use its reasonable best efforts to obtain from           each person
who now has piggyback registration rights a waiver of those rights           with respect
to the Registration Statement. The Registration Statement (and each           amendment
or supplement thereto, and each request for acceleration of           effectiveness
thereof) shall be provided in accordance with Section 3(a) to the           Investors and
their counsel prior to its filing or other submission. If a           Registration
Statement covering the Registrable Securities is not filed with the           Commission
on or prior to the Filing Deadline, the Company will make pro rata           payments to
each Investor, as liquidated damages and not as a penalty, in an           amount equal
to 1% of the aggregate amount invested by such Investor for each           30-day period
or pro rata for any portion thereof following the date by which           such
Registration Statement should have been filed for which no Registration
          Statement is filed with respect to the Registrable Securities. Such payments
          shall be in partial compensation to the Investors, and shall not constitute the
          Investors’ exclusive remedy for such events. Such payments shall be made
to           each Investor in cash. The amounts payable as liquidated damages pursuant to
          this paragraph shall be payable in lawful money of the United States, and
          amounts payable as liquidated damages shall be paid within three (3) Business
          Days of the last day of each such 30-day period during which the Registration
          Statement should have been filed for which no Registration Statement was filed
          with respect to the Registrable Securities.  







	 	        (b)              Upon
the written demand of any Investor and upon any change in the Exercise           Price
(as defined in the Warrant) such that additional shares of Common Stock           become
issuable upon the exercise of the Warrants, the Company shall prepare and           file
with the Commission one or more Registration Statements on Form SB-2 or           amend
the Registration Statement filed pursuant to clause (i) above, if such
          Registration Statement has not previously been declared effective (or, if Form
          SB-2 is not then available to the Company, on such form of registration
          statement as is then available to effect a registration for resale of such
          additional shares of Common Stock (the “Additional Shares”)),
          covering the resale of the Additional Shares, but only to the extent the
          Additional Shares are not at the time covered by an effective Registration
          Statement. Such Registration Statement also shall cover, to the extent
allowable           under the Securities Act and the rules promulgated thereunder
(including Rule           416), such indeterminate number of additional shares of Common
Stock resulting           from stock splits, stock dividends or similar transactions with
respect to the           Additional Shares. The Company shall use its reasonable best
efforts to obtain           from each person who now has piggyback registration rights a
waiver of those           rights with respect to such Registration Statement. The
Registration Statement           (and each amendment or supplement thereto, and each
request for acceleration of           effectiveness thereof) shall be provided in
accordance with Section 3(a) to the           Investors and their counsel prior to its
filing or other submission. If a           Registration Statement covering the Additional
Shares is required to be filed           under this Section 2(a)(ii) and is not filed
with the Commission within 30           Business Days of the request of any Investor or
upon the occurrence of any of           the events specified in this Section 2(a)(ii),
the Company will make pro rata           payments to each Investor, as liquidated damages
and not as a penalty, in an           amount equal to 1% of the aggregate amount invested
by such Investor for each           30-day period or pro rata for any portion thereof
following the date by which           such Registration Statement should have been filed
for which no Registration           Statement is filed with respect to the Additional
Shares. Such payments shall be           in partial compensation to the Investors, and
shall not constitute the           Investors’ exclusive remedy for such events. Such
payments shall be made to           each Investor in cash. The amounts payable as
liquidated damages pursuant to           this paragraph shall be payable in lawful money
of the United States, and           amounts payable as liquidated damages shall be paid
within three (3) Business           Days of the last day of each such 30-day period
during which the Registration           Statement should have been filed for which no
Registration Statement was filed           with respect to the Registrable Securities.  







3 












        3.        Effectiveness.  





	 	        (a)              The
Company shall use commercially reasonable efforts to have the Registration
          Statement declared effective as soon as practicable. The Company shall notify
          the Investors by facsimile or e-mail as promptly as practicable, and in any
          event, within twenty-four (24) hours, after any Registration Statement is
          declared effective and shall simultaneously provide the Investors with copies
of           any related Prospectus to be used in connection with the sale or other
          disposition of the securities covered thereby. If (A)(x) a Registration
          Statement covering the Registrable Securities is not declared effective by the
          Commission within ninety (90) days after the Closing Date (or one hundred
twenty           days if reviewed by the SEC), or (y) a Registration Statement covering
          Additional Shares is not declared effective by the Commission within ninety
(90)           days following the time such Registration Statement was required to be
filed           pursuant to Section 2(a)(ii) (or one hundred twenty days if reviewed by
the           SEC), or (B) after a Registration Statement has been declared effective by
the           Commission, sales cannot be made pursuant to such Registration Statement
for any           reason (including without limitation by reason of a stop order, or the
          Company’s failure to update the Registration Statement), but excluding the
          inability of any Investor to sell the Registrable Securities covered thereby
due           to market conditions and except as excused pursuant to subparagraph (ii)
below,           then the Company will make pro rata payments to each Investor, as
liquidated           damages and not as a penalty, in an amount equal to 1% of the
aggregate amount           invested by such Investor for each 30- day period or pro rata
for any portion           thereof following the date by which such Registration Statement
should have been           effective (the “Blackout Period”). Such
payments shall be in           partial compensation to the Investors, and shall not
constitute the           Investors’ exclusive remedy for such events. The amounts
payable as           liquidated damages pursuant to this paragraph shall be paid monthly
within three           (3) Business Days of the last day of each month following the
commencement of           the Blackout Period until the termination of the Blackout
Period. Such payments           shall be made to each Investor in cash.  







	 	        (b)              For
not more than twenty (20) consecutive days or for a total of not more than
          forty-five (45) days in any twelve (12) month period, the Company may delay the
          disclosure of material non-public information concerning the Company, by
          suspending the use of any Prospectus included in any registration contemplated
          by this Section containing such information, the disclosure of which at the
time           is not, in the good faith opinion of the Company, in the best interests of
the           Company (an “Allowed Delay”); provided, that the Company
shall           promptly (a) notify the Investors in writing of the existence of (but in
no           event, without the prior written consent of an Investor, shall the Company
          disclose to such Investor any of the facts or circumstances regarding) material
          non-public information giving rise to an Allowed Delay, (b) advise the
Investors           in writing to cease all sales under the Registration Statement until
the end of           the Allowed Delay and (c) use commercially reasonable efforts to
terminate an           Allowed Delay as promptly as practicable.  










4 












        4.        Registration
Procedures.  





                    In
connection with the Company’s registration obligations hereunder, the Company shall: 



	 	        (a)              Not
less than five Trading Days prior to the filing of a Registration Statement           or
any related Prospectus or any amendment or supplement thereto, the Company
          shall furnish to each Holders copies of the “Selling Stockholders”          section
of such document, the “Plan of Distribution” and any risk           factor
contained in such document that addresses specifically this transaction           or the
Selling Stockholders, as proposed to be filed which documents will be           subject
to the review of such Holder. The Company shall not file a Registration
          Statement, any Prospectus or any amendments or supplements thereto in which the
          “Selling Stockholder” section thereof differs from the disclosure
          received from a Holder in its Selling Holder Questionnaire (as amended or
          supplemented).  







	 	        (b)              (i)
Use commercially reasonable efforts to cause such Registration Statement to
          become effective and to remain continuously effective for a period that will
          terminate upon the earlier of (1) the date on which all Registrable Securities
          covered by such Registration Statement as amended from time to time, have been
          sold, and (2) the date on which all Registrable Securities covered by such
          Registration Statement may be sold pursuant to Rule 144(k) (the           “Effectiveness
Period”) and advise the Investors in writing           when the Effectiveness
Period has expired; (ii) prepare and file with the           Commission such amendments,
including post-effective amendments, to each           Registration Statement and the
Prospectus used in connection therewith as may be           necessary to keep such
Registration Statement continuously effective as to the           applicable Registrable
Securities for its Effectiveness Period and prepare and           file with the
Commission such additional Registration Statements in order to           register for
resale under the Securities Act all of the Registrable Securities;           (iii) cause
the related Prospectus to be amended or supplemented by any required           Prospectus
supplement, and as so supplemented or amended to be filed pursuant to           Rule 424;
(iv) respond as promptly as reasonably possible to any comments           received from
the Commission with respect to each Registration Statement or any           amendment
thereto and, as promptly as reasonably possible provide the Holders           true and
complete copies of all correspondence from and to the Commission           relating to
such Registration Statement that would not result in the disclosure           to the
Holders of material and non-public information concerning the Company;           and (v)
comply in all material respects with the provisions of the Securities           Act and
the Exchange Act with respect to the Registration Statements and the
          disposition of all Registrable Securities covered by each Registration
          Statement.  












5 











	 	        (c)              Immediately
notify the Holders (and, in the case of (i)(A) below, not less than           three
Trading Days prior to such filing) and (if requested by any such Person)
          confirm such notice in writing no later than one Trading Day following the day
          (i)(A) when a Prospectus or any Prospectus supplement or post-effective
          amendment to a Registration Statement is proposed to be filed; (B) when the
          Commission notifies the Company whether there will be a “review” of
          such Registration Statement and whenever the Commission comments in writing on
          such Registration Statement (the Company shall provide true and complete copies
          thereof and all written responses thereto to each of the Holders that pertain
to           the Holders as a Selling Stockholder or to the Plan of Distribution, but not
          information which the Company believes would constitute material and non-public
          information); and (C) with respect to each Registration Statement or any
          post-effective amendment, when the same has become effective; (ii) of any
          request by the Commission or any other Federal or state governmental authority
          for amendments or supplements to a Registration Statement or Prospectus or for
          additional information; (iii) of the issuance by the Commission of any stop
          order suspending the effectiveness of a Registration Statement covering any or
          all of the Registrable Securities or the initiation of any Proceedings for that
          purpose; (iv) of the receipt by the Company of any notification with respect to
          the suspension of the qualification or exemption from qualification of any of
          the Registrable Securities for sale in any jurisdiction, or the initiation or
          threatening of any Proceeding for such purpose; and (v) of the occurrence of
any           event or passage of time that makes the financial statements included in a
          Registration Statement ineligible for inclusion therein or any statement made
in           such Registration Statement or Prospectus or any document incorporated or
deemed           to be incorporated therein by reference untrue in any material respect
or that           requires any revisions to such Registration Statement, Prospectus or
other           documents so that, in the case of such Registration Statement or the
Prospectus,           as the case may be, it will not contain any untrue statement of a
material fact           or omit to state any material fact required to be stated therein
or necessary to           make the statements therein, in light of the circumstances
under which they were           made, not misleading.  







	 	        (d)              Use
its reasonable best efforts to avoid the issuance of, or, if issued, obtain           the
withdrawal of (i) any order suspending the effectiveness of a Registration
          Statement, or (ii) any suspension of the qualification (or exemption from
          qualification) of any of the Registrable Securities for sale in any
          jurisdiction, at the earliest practicable moment.  







	 	        (e)              Upon
request, furnish to each Holder, without charge, at least one conformed           copy of
each Registration Statement and each amendment thereto and all exhibits           to the
extent requested by such Person (including those previously furnished)           promptly
after the filing of such documents with the Commission.  







	 	        (f)              Promptly
deliver to each Holder, without charge, as many copies of each           Prospectus or
Prospectuses (including each form of prospectus) and each           amendment or
supplement thereto as such Persons may reasonably request. The           Company hereby
consents to the use of such Prospectus and each amendment or           supplement thereto
by each of the selling Holders in connection with the           offering and sale of the
Registrable Securities covered by such Prospectus and           any amendment or
supplement thereto.  








6 











	 	        (g)              Prior
to any public offering of Registrable Securities, to register or qualify           or
cooperate with the selling Holders in connection with the registration or
          qualification (or exemption from such registration or qualification) of such
          Registrable Securities for offer and sale under the securities or Blue Sky laws
          of all jurisdictions within the United States, to keep each such registration
or           qualification (or exemption therefrom) effective during the Effectiveness
Period           and to do any and all other acts or things necessary or advisable to
enable the           disposition in such jurisdictions of the Registrable Securities
covered by the           Registration Statements; provided, however, that the Company
shall not be           required in connection therewith as a condition thereto to qualify
to do           business or to file a general consent to service of process in any such
states           or jurisdictions.  







	 	        (h)              Cooperate
with the Holders to facilitate the timely preparation and delivery of
          certificates representing Registrable Securities to be delivered to a
transferee           pursuant to the Registration Statements, which certificates shall be
free, to           the extent permitted by the Purchase Agreement, of all restrictive
legends, and           to enable such Registrable Securities to be in such denominations
and registered           in such names as any such Holders may request.  







	 	        (i)              Upon
the occurrence of any event contemplated by Section 3(c)(v), as promptly as
          reasonably possible, prepare a supplement or amendment, including a
          post-effective amendment, to the affected Registration Statements or a
          supplement to the related Prospectus or any document incorporated or deemed to
          be incorporated therein by reference, and file any other required document so
          that, as thereafter delivered, no Registration Statement nor any Prospectus
will           contain an untrue statement of a material fact or omit to state a material
fact           required to be stated therein or necessary to make the statements therein,
in           light of the circumstances under which they were made, not misleading.  







	 	        (j)              Otherwise
use commercially reasonable efforts to comply with all applicable           rules and
regulations of the Commission under the Securities Act and the           Exchange Act,
take such other actions as may be reasonably necessary to           facilitate the
registration of the Registrable Securities hereunder; and make           available to its
security holders, as soon as reasonably practicable, but not           later than the
Availability Date (as defined below), an earnings statement           covering a period
of at least twelve (12) months, beginning after the effective           date of each
Registration Statement, which earnings statement shall satisfy the           provisions
of Section 11(a) of the Securities Act, including Rule 158           promulgated
thereunder (for the purpose of this subsection 3(j),           “Availability Date” means
the 45th day following the end of the           fourth fiscal quarter that includes the
effective date of such Registration           Statement, except that, if such fourth
fiscal quarter is the last quarter of the           Company’s fiscal year, “Availability
Date” means the 90th           day after the end of such fourth fiscal quarter).  







	 	        (k)              With
a view to making available to the Investors the benefits of Rule 144 (or           its
successor rule) and any other rule or regulation of the Commission that may           at
any time permit the Investors to sell shares of Common Stock to the public
          without registration, the Company covenants and agrees to: (i) make and keep
          public information available, as those terms are understood and defined in Rule
          144, until the earlier of (A) six months after such date as all of the
          Registrable Securities may be resold pursuant to Rule 144(k) or any other rule
          of similar effect or (B) such date as all of the Registrable Securities shall
          have been resold; (ii) file with the Commission in a timely manner all reports
          and other documents required of the Company under the Exchange Act; and (iii)
          furnish to each Investor upon request, as long as such Investor owns any
          Registrable Securities, (A) a written statement by the Company that it has
          complied with the reporting requirements of the Exchange Act, (B) a copy of the
          Company’s most recent Annual Report on Form 10-K or Quarterly Report on
          Form 10-Q, and (C) such other information as may be reasonably requested in
          order to avail such Investor of any rule or regulation of the Commission that
          permits the selling of any such Registrable Securities without registration.  








7 











        5.        Registration
Expenses. All fees and expenses incident to the performance           of or
compliance with this Agreement by the Company shall be borne by the           Company
whether or not any Registrable Securities are sold pursuant to a           Registration
Statement. The fees and expenses referred to in the foregoing           sentence shall
include, without limitation, (i) all registration and filing fees           (including,
without limitation, fees and expenses (A) with respect to filings           required to
be made with any Trading Market on which the Common Stock is then           listed for
trading, and (B) in compliance with applicable state securities or           Blue Sky
laws), (ii) printing expenses (including, without limitation, expenses           of
printing certificates for Registrable Securities and of printing prospectuses
          if the printing of prospectuses is reasonably requested by the holders of a
          majority of the Registrable Securities included in the Registration Statement),
          (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements
of           counsel for the Company, (v) Securities Act liability insurance, if the
Company           so desires such insurance, and (vi) fees and expenses of all other
Persons           retained by the Company in connection with the consummation of the
transactions           contemplated by this Agreement. In addition, the Company shall be
responsible           for all of its internal expenses incurred in connection with the
consummation of           the transactions contemplated by this Agreement (including,
without limitation,           all salaries and expenses of its officers and employees
performing legal or           accounting duties), the expense of any annual audit and the
fees and expenses           incurred in connection with the listing of the Registrable
Securities on any           securities exchange as required hereunder. Each Holder shall
pay all           underwriting discounts, selling commissions or other selling expenses
incurred           in connection with any sale or other disposition of Registrable
Securities.  





	 	        (a)       Due
Diligence Review; Information. Subject to subsection (b) below, the           Company
shall make available, during normal business hours, for inspection and           review
by the Investors, advisors to and representatives of the Investors (who           may or
may not be affiliated with the Investors and who are reasonably           acceptable to
the Company), all financial and other records, all SEC Filings (as           defined in
the Purchase Agreement) and other filings with the Commission, all           other
corporate documents and properties of the Company as may be reasonably
          necessary for the purpose of such review, and cause the Company’s
officers,           directors and employees, within a reasonable time period, to supply
all such           information reasonably requested by the Investors or any such
representative,           advisor or underwriter in connection with such Registration
Statement           (including, without limitation, in response to all questions and
other inquiries           reasonably made or submitted by any of them), prior to and from
time to time           after the filing and effectiveness of the Registration Statement,
all such           information for the sole purpose of enabling the Investors and such
          representatives, advisors and underwriters and their respective accountants and
          attorneys to conduct initial and ongoing due diligence with respect to the
          Company and the accuracy of such Registration Statement.  







	 	        (b)       Material,
Non-Public Information. After the Closing (as defined in the           Purchase
Agreement), the Company shall not disclose material non-public           information to
any Investor, or to advisors or representatives of such Investor,           unless prior
to disclosure of such information the Company identifies such           information as
being material, non-public information and provides such           Investor, advisor or
representative with the opportunity to accept or refuse to           accept such
material, non-public information for review and if such Investor           wishes to
obtain such information, such Investor enters into an appropriate
          confidentiality agreement with the Company with respect thereto.  








8 












        6.        Obligations
of the Investors.  





	 	        (a)              Each
Investor agrees to furnish to the Company a completed Questionnaire in the           form
attached to this Agreement as Annex B (a “Selling Holder
          Questionnaire”) at least two (2) Business Days prior to the first
          anticipated filing date of such Registration Statement if such Investor elects
          to have any of the Registrable Securities included in the Registration
          Statement. If any Investor fails to provide a complete and accurate Selling
          Holder Questionnaire at least two (2) Business Days prior to the first
          anticipated filing date of such Registration Statement, then such Investor
shall           be deemed to have waived and relinquished the registration rights set
forth in           this Agreement and shall thereafter not be entitled to any liquidated
damages as           provided for herein.  







	 	        (b)              Each
Investor, by its acceptance of the Registrable Securities agrees to           cooperate
with the Company as reasonably requested by the Company in connection           with the
preparation and filing of a Registration Statement hereunder, unless           such
Investor has notified the Company in writing of its election to exclude all           of
its Registrable Securities from such Registration Statement.  







	 	        (c)              Each
Investor agrees that, upon receipt of any notice from the Company of either           (i)
the commencement of an Allowed Delay pursuant to Section 2(b)(ii) or (ii)           the
happening of an event pursuant to Section 3(c)(i)(C) hereof, such Investor           will
immediately discontinue disposition of Registrable Securities pursuant to           the
Registration Statement covering such Registrable Securities, until the           Investor’s
receipt of the copies of the supplemented or amended prospectus           filed with the
Commission and until any related post-effective amendment is           declared effective
and, if so directed by the Company, the Investor shall           deliver to the Company
(at the expense of the Company) or destroy (and deliver           to the Company a
certificate of destruction) all copies in the Investor’s           possession of the
Prospectus covering the Registrable Securities current at the           time of receipt
of such notice.  







        7.         Indemnification.  





	 	        (a)    Indemnification
by the Company. The Company will indemnify and hold           harmless each Holder
and its officers, directors, members, employees and agents,           successors and
assigns, and each other person, if any, who controls such Holder           within the
meaning of the Securities Act, against any losses, claims, damages or
          liabilities, (including reasonable attorney fees) (collectively,
          “Losses”), joint or several, to which they may become subject
          under the Securities Act or otherwise, insofar as such Losses (or actions in
          respect thereof) arise out of or are based upon: (i) any untrue statement or
          alleged untrue statement of any material fact contained in any Registration
          Statement, any preliminary prospectus or final prospectus contained therein, or
          any amendment or supplement thereof; (ii) any blue sky application or other
          document executed by the Company specifically for that purpose or based upon
          written information furnished by the Company filed in any state or other
          jurisdiction in order to qualify any or all of the Registrable Securities under
          the securities laws thereof (any such application, document or information
          herein called a “Blue Sky Application”); (iii) the
          omission or alleged omission to state therein a material fact required to be
          stated therein or necessary to make the statements therein not misleading; (iv)
          any violation by the Company or its agents of any rule or regulation
promulgated           under the Securities Act applicable to the Company or its agents
and relating to           action or inaction required of the Company in connection with
such registration;           or (v) any failure to register or qualify the Registrable
Securities included in           any such Registration in any state where the Company or
its agents has           affirmatively undertaken or agreed in writing that the Company
will undertake           such registration or qualification on an Investor’s behalf
and will           reimburse such Holder, and each such officer, director or member and
each such           controlling person for any legal or other expenses reasonably
incurred by them           in connection with investigating or defending any such loss,
claim, damage,           liability or action; provided, however, that the
Company will not           be liable in any such case if and to the extent that any such
loss, claim,           damage or liability arises out of or is based upon an untrue
statement or           alleged untrue statement or omission or alleged omission so made
in conformity           with information furnished by such Investor or any such
controlling person in           writing specifically for use in such Registration
Statement or Prospectus  







9 












	 	        (b)    Indemnification
by Holders. Each Holder agrees, severally but not           jointly, to indemnify and
hold harmless, to the fullest extent permitted by law,           the Company, its
directors, officers, employees and each person who controls the           Company (within
the meaning of the Securities Act) against any Losses resulting           from (i) any
untrue statement of a material fact or any omission of a material           fact required
to be stated in the Registration Statement or Prospectus or           preliminary
prospectus or amendment or supplement thereto or necessary to make           the
statements therein not misleading, to the extent, but only to the extent           that
such untrue statement or omission is contained in any information furnished           in
writing by such Holder to the Company specifically for inclusion in such
          Registration Statement or Prospectus or amendment or supplement thereto, or
(ii)           any violation by such Holder of the Securities Act. In no event shall the
          liability of a Holder be greater in amount than the dollar amount of the
          proceeds (net of all expense paid by such Investor in connection with any claim
          relating to this Section 7 and the amount of any damages such Investor has
          otherwise been required to pay by reason of such untrue statement or omission)
          received by such Investor upon the sale of the Registrable Securities included
          in the Registration Statement giving rise to such indemnification obligation.  







	 	        (c)    Conduct
of Indemnification Proceedings. If any Proceeding shall be           brought or
asserted against any Person entitled to indemnity hereunder (an           “Indemnified
Party”), such Indemnified Party shall promptly           notify the Person from
whom indemnity is sought (the “Indemnifying           Party”) in
writing, and the Indemnifying Party shall assume the defense           thereof, including
the employment of counsel reasonably satisfactory to the           Indemnified Party and
the payment of all fees and expenses incurred in           connection with defense
thereof; provided, that the failure of any Indemnified           Party to give such
notice shall not relieve the Indemnifying Party of its           obligations or
liabilities pursuant to this Agreement, except (and only) to the           extent that it
shall be finally determined by a court of competent jurisdiction           (which
determination is not subject to appeal or further review) that such           failure
shall have proximately and materially adversely prejudiced the           Indemnifying
Party.  







	 	        (d)              An
Indemnified Party shall have the right to employ separate counsel in any such
          Proceeding and to participate in the defense thereof, but the fees and expenses
          of such counsel shall be at the expense of such Indemnified Party or Parties
          unless: (1) the Indemnifying Party has agreed in writing to pay such fees and
          expenses; (2) the Indemnifying Party shall have failed promptly to assume the
          defense of such Proceeding and to employ counsel reasonably satisfactory to
such           Indemnified Party in any such Proceeding; or (3) the named parties to any
such           Proceeding (including any impleaded parties) include both such Indemnified
Party           and the Indemnifying Party, and such Indemnified Party shall have been
advised           by counsel that a conflict of interest is likely to exist if the same
counsel           were to represent such Indemnified Party and the Indemnifying Party (in
which           case, if such Indemnified Party notifies the Indemnifying Party in
writing that           it elects to employ separate counsel at the expense of the
Indemnifying Party,           the Indemnifying Party shall not have the right to assume
the defense thereof           and such counsel shall be at the expense of the
Indemnifying Party). The           Indemnifying Party shall not be liable for any
settlement of any such Proceeding           effected without its written consent, which
consent shall not be unreasonably           withheld. No Indemnifying Party shall,
without the prior written consent of the           Indemnified Party, effect any
settlement of any pending Proceeding in respect of           which any Indemnified Party
is a party, unless such settlement includes an           unconditional release of such
Indemnified Party from all liability on claims           that are the subject matter of
such Proceeding.  








10 











	 	        (e)              All
fees and expenses of the Indemnified Party (including reasonable fees and
          expenses to the extent incurred in connection with investigating or preparing
to           defend such Proceeding in a manner not inconsistent with this Section) shall
be           paid to the Indemnified Party, as incurred, within ten Trading Days of
written           notice thereof to the Indemnifying Party (regardless of whether it is
ultimately           determined that an Indemnified Party is not entitled to
indemnification           hereunder; provided, that the Indemnifying Party may require
such Indemnified           Party to undertake to reimburse all such fees and expenses to
the extent it is           finally judicially determined that such Indemnified Party is
not entitled to           indemnification hereunder).  







	 	        (f)    Contribution.
If for any reason the indemnification provided for in the           preceding paragraphs
(a) and (b) is unavailable to an indemnified party or           insufficient to hold it
harmless, other than as expressly specified therein,           then the Indemnifying
Party shall contribute to the amount paid or payable by           the Indemnified Party
as a result of such loss, claim, damage or liability in           such proportion as is
appropriate to reflect the relative fault of the           Indemnified Party and the
Indemnifying Party, as well as any other relevant           equitable considerations. No
person guilty of fraudulent misrepresentation           within the meaning of Section
11(f) of the Securities Act shall be entitled to           contribution from any person
not guilty of such fraudulent misrepresentation. In           no event shall the
contribution obligation of a holder of Registrable Securities           be greater in
amount than the dollar amount of the proceeds (net of all expenses           paid by such
holder in connection with any claim relating to this Section 7 and           the amount
of any damages such holder has otherwise been required to pay by           reason of such
untrue or alleged untrue statement or omission or alleged           omission) received by
it upon the sale of the Registrable Securities giving rise           to such contribution
obligation.  







        The
indemnity and contribution agreements contained in this Section are in addition to any
liability that the Indemnifying Parties may have to the Indemnified Parties.  





        8.        Miscellaneous.  





	 	        (a)    Remedies.
In the event of a breach by the Company or by a Holder, of any           of their
obligations under this Agreement, each Holder or the Company, as the           case may
be, in addition to being entitled to exercise all rights granted by law           and
under this Agreement, including recovery of damages, will be entitled to
          specific performance of its rights under this Agreement. The Company and each
          Holder agree that monetary damages would not provide adequate compensation for
          any losses incurred by reason of a breach by it of any of the provisions of
this           Agreement and hereby further agrees that, in the event of any action for
          specific performance in respect of such breach, it shall waive the defense that
          a remedy at law would be adequate.  







11 












	 	        (b)    No
Piggyback on Registrations. Except as and to the extent specified in
          Schedule 3.1(s) to the Purchase Agreement, neither the Company nor any of its
          security holders (other than the Holders in such capacity pursuant hereto) may
          include securities of the Company in a Registration Statement other than the
          Registrable Securities, and the Company shall not during the Registration
Period           enter into any agreement providing any such right to any of its security
          holders.  







	 	        (c)    Compliance.
Each Holder covenants and agrees that it will comply with the           prospectus
delivery requirements of the Securities Act as applicable to it in           connection
with sales of Registrable Securities pursuant to the Registration           Statement.  







	 	        (d)    Piggy-Back
Registrations. If at any time during the Effectiveness Period           there is not
an effective Registration Statement covering all of the Registrable           Securities
and the Company shall determine to prepare and file with the           Commission a
registration statement relating to an offering for its own account           or the
account of others under the Securities Act of any of its equity           securities,
other than on Form S-4 or Form S-8 (each as promulgated under the           Securities
Act) or their then equivalents relating to equity securities to be           issued
solely in connection with any acquisition of any entity or business or           equity
securities issuable in connection with stock option or other employee           benefit
plans, then the Company shall send to each Holder written notice of such
          determination and, if within fifteen days after receipt of such notice, any
such           Holder shall so request in writing, the Company shall include in such
          registration statement all or any part of such Registrable Securities such
          holder requests to be registered, subject to customary underwriter cutbacks
          applicable to all holders of registration rights.  







	 	        (e)    Amendments
and Waivers. The provisions of this Agreement, including the           provisions of
this Section 8(e), may not be amended, modified or supplemented,           and waivers or
consents to departures from the provisions hereof may not be           given, unless the
same shall be in writing and signed by the Company and the           Holders of no less
than a majority in interest of the then outstanding           Registrable Securities.
Notwithstanding the foregoing, a waiver or consent to           depart from the
provisions hereof with respect to a matter that relates           exclusively to the
rights of certain Holders and that does not directly or           indirectly affect the
rights of other Holders may be given by Holders of at           least a majority of the
Registrable Securities to which such waiver or consent           relates.  







	 	        (f)    Notices.
Any and all notices or other communications or deliveries           required or permitted
to be provided hereunder shall be in writing and shall be           deemed given and
effective on the earliest of (a) the date of transmission, if           such notice or
communication is delivered via facsimile (provided the sender           receives a
machine-generated confirmation of successful transmission) at the           facsimile
number specified in this Section prior to 6:30 p.m. (New York City           time) on a
Trading Day, (b) the next Trading Day after the date of transmission,           if such
notice or communication is delivered via facsimile at the facsimile           number
specified in this Section on a day that is not a Trading Day or later           than 6:30
p.m. (New York City time) on any Trading Day, (c) the Trading Day           following the
date of mailing, if sent by U.S. nationally recognized overnight           courier
service, or (d) upon actual receipt by the party to whom such notice is
          required to be given. The address for such notices and communications shall be
          as follows:  








12 











		
	If to the Company:	Alliance Pharmaceutical Corp.
		6175 Lusk Boulevard
		San Diego, CA 92121
		Attn: Chief Financial Officer
		Facsimile: (858) 410-5201
	
With a copy to:	Foley & Lardner LLP
		402 W. Broadway, 23rd Floor
		San Diego, CA 92101
		Attn: Kenneth D. Polin, Esq.
		Facsimile: (619) 234-3510
	
If to a Investor:	To the address set forth under such Investor's name 
		on the signature pages hereto.
	
With a copy to:	Lowenstein Sandler PC
		1251 Avenue of the Americas, 18th Floor
		New York, New York 10020
		Attn: Steven E. Siesser, Esq.
		Fax: (973) 597-2507







		
	If
to any other Person who 
is then the registered Holder:	To the address of such Holder
as it appears in the stock transfer books of the Company







	 	
or
such other address as may be designated in writing hereafter, in the same manner, by such
Person.  






	 	        (g)    Successors
and Assigns. This Agreement shall inure to the benefit of and           be binding
upon the successors and permitted assigns of each of the parties and           shall
inure to the benefit of each Holder. Each Holder may assign their           respective
rights hereunder in the manner and to the Persons as permitted under           the
Purchase Agreement.  







	 	        (h)    Execution
and Counterparts. This Agreement may be executed in any number           of
counterparts, each of which when so executed shall be deemed to be an           original
and, all of which taken together shall constitute one and the same           Agreement.
In the event that any signature is delivered by facsimile           transmission, such
signature shall create a valid binding obligation of the           party executing (or on
whose behalf such signature is executed) the same with           the same force and
effect as if such facsimile signature were the original           thereof.  









13 












	 	        (i)    Governing
Law. All questions concerning the construction, validity,           enforcement and
interpretation of this Agreement shall be governed by and           construed and
enforced in accordance with the internal laws of the State of New           York, without
regard to the principles of conflicts of law thereof. Each party           agrees that
all Proceedings concerning the interpretations, enforcement and           defense of the
transactions contemplated by this Agreement (whether brought           against a party
hereto or its respective Affiliates, employees or agents) will           be commenced in
the New York Courts. Each party hereto hereby irrevocably           submits to the
exclusive jurisdiction of the New York Courts for the           adjudication of any
dispute hereunder or in connection herewith or with any           transaction
contemplated hereby or discussed herein, and hereby irrevocably           waives, and
agrees not to assert in any Proceeding, any claim that it is not           personally
subject to the jurisdiction of any New York Court, or that such           Proceeding has
been commenced in an improper or inconvenient forum. Each party           hereto hereby
irrevocably waives personal service of process and consents to           process being
served in any such Proceeding by mailing a copy thereof via           registered or
certified mail or overnight delivery (with evidence of delivery)           to such party
at the address in effect for notices to it under this Agreement           and agrees that
such service shall constitute good and sufficient service of           process and notice
thereof. Nothing contained herein shall be deemed to limit in           any way any right
to serve process in any manner permitted by law. Each party           hereto hereby
irrevocably waives, to the fullest extent permitted by applicable           law, any and
all right to trial by jury in any Proceeding arising out of or           relating to this
Agreement or the transactions contemplated hereby. If either           party shall
commence a Proceeding to enforce any provisions of this Agreement,           then the
prevailing party in such Proceeding shall be reimbursed by the other           party for
its attorney’s fees and other costs and expenses incurred with           the
investigation, preparation and prosecution of such Proceeding.  







	 	        (j)    Cumulative
Remedies. The remedies provided herein are cumulative and not           exclusive of
any remedies provided by law.  







	 	        (k)    Severability.
If any term, provision, covenant or restriction of this           Agreement is held by a
court of competent jurisdiction to be invalid, illegal,           void or unenforceable,
the remainder of the terms, provisions, covenants and           restrictions set forth
herein shall remain in full force and effect and shall in           no way be affected,
impaired or invalidated, and the parties hereto shall use           their reasonable
efforts to find and employ an alternative means to achieve the           same or
substantially the same result as that contemplated by such term,           provision,
covenant or restriction. It is hereby stipulated and declared to be           the
intention of the parties that they would have executed the remaining terms,
          provisions, covenants and restrictions without including any of such that may
be           hereafter declared invalid, illegal, void or unenforceable.  







	 	        (l)    Headings.
The headings in this Agreement are for convenience of reference           only and shall
not limit or otherwise affect the meaning hereof.  











14 












	 	        (m)    Independent
Nature of Investors’ Obligations and Rights. The           obligations of each
Holder under this Agreement are several and not joint with           the obligations of
each other Holder, and no Holder shall be responsible in any           way for the
performance of the obligations of any other Holder under this           Agreement.
Nothing contained herein or in any Transaction Document, and no           action taken by
any Holder pursuant thereto, shall be deemed to constitute the           Holders as a
partnership, an association, a joint venture or any other kind of           entity, or
create a presumption that the Holders are in any way acting in           concert or as a
group with respect to such obligations or the transactions           contemplated by this
Agreement or any other Transaction Document. Each Holder           acknowledges that no
other Holder will be acting as agent of such Holder in           enforcing its rights
under this Agreement. Each Holder shall be entitled to           independently protect
and enforce its rights, including without limitation the           rights arising out of
this Agreement, and it shall not be necessary for any           other Holder to be joined
as an additional party in any Proceeding for such           purpose. The Company
acknowledges that each of the Holders has been provided           with the same
Registration Rights Agreement for the purpose of closing a           transaction with
multiple Holders and not because it was required or requested           to do so by any
Investor.  







[REMAINDER OF PAGE
INTENTIONALLY LEFT BLANK
SIGNATURE PAGES TO FOLLOW] 























15 














        IN
WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first written above. 



		ALLIANCE PHARMACEUTICAL CORP.



		
By:   	
 

			Name:
			Title:








[REMAINDER OF PAGE
INTENTIONALLY LEFT BLANK
SIGNATURE PAGES OF INVESTORS
TO FOLLOW] 



















16 

















        IN
WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first written above. 




		NAME OF INVESTING ENTITY



		 







		AUTHORIZED SIGNATORY


			
		
By:  	
 

		Name:  	 
		Title:  	 







		ADDRESS FOR NOTICE


		 	
		c/o:  	 

		Street:  	 

		City/State/Zip: 	 

		Attention:  	 

		Tel:  	 

		Fax:  	 

		Email:  	 














17 














Annex A 



Plan of Distribution 



        The
selling stockholders, which as used herein includes donees, pledgees, transferees or other
successors-in-interest selling shares of common stock or interests in shares of common
stock received after the date of this prospectus from a selling stockholder as a gift,
pledge, partnership distribution or other transfer, may, from time to time, sell, transfer
or otherwise dispose of any or all of their shares of common stock or interests in shares
of common stock on any stock exchange, market or trading facility on which the shares are
traded or in private transactions. These dispositions may be at fixed prices, at
prevailing market prices at the time of sale, at prices related to the prevailing market
price, at varying prices determined at the time of sale, or at negotiated prices. 



        The
selling stockholders may use any one or more of the following methods when disposing of
shares or interests therein: 



        —
ordinary brokerage transactions and transactions in which the broker-dealer solicits
purchasers; 



        —
block trades in which the broker-dealer will attempt to sell the shares as agent, but may
position and resell a portion of the block as principal to facilitate the transaction; 



        —
purchases by a broker-dealer as principal and resale by the broker-dealer for its account; 



        — an
exchange distribution in accordance with the rules of the applicable exchange; 



        — privately
negotiated transactions; 




        — short sales effected after the date of this Prospectus; 



        — through the writing or settlement of options or other hedging  transactions,  whether
through an options exchange or otherwise; 




        — broker-dealers
may agree with the selling stockholders to sell a specified number of such shares at a
stipulated price per share; 



        —
a combination of any such methods of sale; and 



        — any
other method permitted pursuant to applicable law. 











18 











        The
selling stockholders may, from time to time, pledge or grant a security interest in some
or all of the shares of common stock owned by them and, if they default in the performance
of their secured obligations, the pledgees or secured parties may offer and sell the
shares of common stock, from time to time, under this prospectus, or under an amendment to
this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act
amending the list of selling stockholders to include the pledgee, transferee or other
successors in interest as selling stockholders under this prospectus. The selling
stockholders also may transfer the shares of common stock in other circumstances, in which
case the transferees, pledgees or other successors in interest will be the selling
beneficial owners for purposes of this prospectus. 



        In
connection with the sale of our common stock or interests therein, the selling
stockholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the common stock in the course of
hedging the positions they assume. The selling stockholders may also sell shares of our
common stock short and deliver these securities to close out their short positions, or
loan or pledge the common stock to broker-dealers that in turn may sell these securities.
The selling stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or the creation of one or more derivative
securities which require the delivery to such broker-dealer or other financial institution
of shares offered by this prospectus, which shares such broker-dealer or other financial
institution may resell pursuant to this prospectus (as supplemented or amended to reflect
such transaction). 



        The
aggregate proceeds to the selling stockholders from the sale of the common stock offered
by them will be the purchase price of the common stock less discounts or commissions, if
any. Each of the selling stockholders reserves the right to accept and, together with
their agents from time to time, to reject, in whole or in part, any proposed purchase of
common stock to be made directly or through agents. We will not receive any of the
proceeds from this offering. Upon any exercise of the warrants by payment of cash,
however, we will receive the exercise price of the warrants. 



        The
selling stockholders also may resell all or a portion of the shares in open market
transactions in reliance upon Rule 144 under the Securities Act of 1933, provided that
they meet the criteria and conform to the requirements of that rule. 



        The
selling stockholders and any underwriters, broker-dealers or agents that participate in
the sale of the common stock or interests therein may be “underwriters” within
the meaning of Section 2(11) of the Securities Act. Any discounts, commissions,
concessions or profit they earn on any resale of the shares may be underwriting discounts
and commissions under the Securities Act. Discounts, concessions, commissions and similar
selling expenses, if any, that can be attributed to the sale of the Securities will be
paid by the Selling Stockholder and/or the purchasers. Each Selling Stockholder has
represented and warranted to the Company that it acquired the securities subject to this
registration statement in the ordinary course of such Selling Stockholder’s business
and, at the time of its purchase of such securities such Selling Stockholder had no
agreements or understandings, directly or indirectly, with any person to distribute any
such securities. The Company has advised each Selling Stockholder that it may not use
shares registered under this registration statement to cover short sales of Common Stock
made prior to the date on which this registration statement shall have been declared
effective by the Commission. Selling stockholders who are “underwriters” within
the meaning of Section 2(11) of the Securities Act will be subject to the prospectus
delivery requirements of the Securities Act. 



19 












        To
the extent required, the shares of our common stock to be sold, the names of the selling
stockholders, the respective purchase prices and public offering prices, the names of any
agents, dealer or underwriter, any applicable commissions or discounts with respect to a
particular offer will be set forth in an accompanying prospectus supplement or, if
appropriate, a post-effective amendment to the registration statement that includes this
prospectus. 



        In
order to comply with the securities laws of some states, if applicable, the common stock
may be sold in these jurisdictions only through registered or licensed brokers or dealers.
In addition, in some states the common stock may not be sold unless it has been registered
or qualified for sale or an exemption from registration or qualification requirements is
available and is complied with. 



        We
have advised the selling stockholders that the anti-manipulation rules of Regulation M
under the Exchange Act may apply to sales of shares in the market and to the activities of
the selling stockholders and their affiliates. In addition, we will make copies of this
prospectus (as it may be supplemented or amended from time to time) available to the
selling stockholders for the purpose of satisfying the prospectus delivery requirements of
the Securities Act. The selling stockholders may indemnify any broker-dealer that
participates in transactions involving the sale of the shares against certain liabilities,
including liabilities arising under the Securities Act. 



        We
have agreed to indemnify the selling stockholders against liabilities, including
liabilities under the Securities Act and state securities laws, relating to the
registration of the shares offered by this prospectus. 



        We
have agreed with the selling stockholders to keep the registration statement of which this
prospectus constitutes a part effective until the earlier of (1) such time as all of the
shares covered by this prospectus have been disposed of pursuant to and in accordance with
the registration statement or (2) the date on which the shares may be sold pursuant to
Rule 144(k) of the Securities Act. 











20 














Annex B 



ALLIANCE
PHARMACEUTICAL CORP. 



Selling Securityholder
Notice and Questionnaire 



The undersigned beneficial owner of
common stock (the “Common Stock”), of Alliance Pharmaceutical Corp. (the
“Company”) understands that the Company has filed or intends to file with
the Securities and Exchange Commission (the “Commission”) a Registration
Statement for the registration and resale of the Registrable Securities, in accordance
with the terms of the Registration Rights Agreement, dated as of May [   ], 2004 (the
“Registration Rights Agreement”), among the Company and the Investors
named therein. A copy of the Registration Rights Agreement is available from the Company
upon request at the address set forth below. All capitalized terms used and not otherwise
defined herein shall have the meanings ascribed thereto in the Registration Rights
Agreement. 



The undersigned hereby provides the
following information to the Company and represents and warrants that such information is
accurate: 



QUESTIONNAIRE 



	1.  	Name.  








	 	(a)	Full
Legal Name of Selling Securityholder

 









	 	(b)	Full
Legal Name of Registered Holder (if not the same as (a) above) through
               which Registrable Securities Listed in Item 3 below are held:

 









	 	(c)	Full
Legal Name of Natural Control Person (which means a natural person who
               directly you indirectly alone or with others has power to vote or dispose
of the                securities covered by the questionnaire):

 











	2.  	Address
for Notices to Selling Securityholder:  
	 	  

	 	  

	 	  

	 	Telephone:

	 	Fax:

	 	Contact Person:










21 












	3.  	Beneficial
Ownership of Registrable Securities:  








	 	(a)	Type
and Principal Amount of Registrable Securities beneficially owned: 
			 

			 

			 









	4.  	Broker-Dealer
Status:  








	 	(a)	Are
you a broker-dealer? 
	
Yes    |_|            No    |_| 







	 	         Note: 	If
yes, the Commission's staff has indicated that you should be identified as an underwriter
in                   the Registration Statement. 






	 	(b)	Are
you an affiliate of a broker-dealer? 
	
Yes    |_|            No    |_| 








	 	(c) 	If
you are an affiliate of a broker-dealer, do you certify that you bought the
               Registrable Securities in the ordinary course of business, and at the time
of                the purchase of the Registrable Securities to be resold, you had no
agreements                or understandings, directly or indirectly, with any person to
distribute the                Registrable Securities? 
	
Yes    |_|            No    |_| 







	 	         Note: 	If
no, the Commission's staff has indicated that you should be identified as an underwriter
in                   the Registration Statement. 







	5. 	Beneficial
Ownership of Other Securities of the Company Owned by the Selling
          Securityholder.








	 	
Except
as set forth below in this Item 5, the undersigned is not the beneficial or registered
owner of  any securities of the Company other than the Registrable Securities
listed above in Item 3. 






	 	(a)	Type
and Amount of Other Securities beneficially owned by the Selling
          Securityholder: 
			 

			 

			 












22 











	6.  	Relationships
with the Company:  








	 	Except as
set forth below, neither the undersigned nor any of its affiliates, officers, directors
or principal equity holders (owners of 5% of more of the equity securities of the
undersigned) has held any position or office or has had any other material
relationship with the Company (or its predecessors or affiliates) during the past
three years.

State
any exceptions here:

 
	 	  

	 	  

	 	  










The undersigned agrees to promptly
notify the Company of any inaccuracies or changes in the information provided herein that
may occur subsequent to the date hereof and prior to the Effective Date for the
Registration Statement. 



By signing below, the undersigned
consents to the disclosure of the information contained herein in its answers to Items 1
through 6 and the inclusion of such information in the Registration Statement and the
related prospectus. The undersigned understands that such information will be relied upon
by the Company in connection with the preparation or amendment of the Registration
Statement and the related prospectus. 



IN WITNESS WHEREOF the undersigned,
by authority duly given, has caused this Notice and Questionnaire to be executed and
delivered either in person or by its duly authorized agent. 





		Beneficial Owner:

	Dated: ______________________	
By:   	
 

			Name:
			Title:







PLEASE FAX A COPY OF THE COMPLETED
AND EXECUTED NOTICE AND QUESTIONNAIRE, AND RETURN THE ORIGINAL BY OVERNIGHT MAIL, TO: 




[               ] 









23